CT Contrast Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
| Term | Definition |
| Iopamidol | ISOVUE. Low-osmolar (LOCM). NON-IONIC. Non-salts that DO NOT dissociate. Less adverse reactions |
| Ioversol | OPTIRAY. Low-osmolar (LOCM). NON-IONIC. Non-salts that DO NOT dissociate. Less adverse reactions |
| Iohexol | OMNIOPAQUE. Low-osmolar (LOCM). NON-IONIC. Non-salts that DO NOT dissociate. Less adverse reactions |
| Diatrizoate | HYPAQUE. High-osmolar (HOCM). IONIC. Salts (sodium/meglumine) that DO dissociate into 2+ ions. |
| Iothalamate | CONRAY. High-osmolar (HOCM). IONIC. Salts (sodium/meglumine) that DO dissociate into 2+ ions. |
| Iodixanol | VISIPAQUE. Iso-osmolar. Same osmolality as blood. Neutral. |
| Fludeoxyglucose (FDG) | F 18. Nuclear Medicine used for PET scans. Typical dose is 10-15 (mCi). Pt's blood glucose must be 150mg/dL or below & have fasted 6-12 hrs prior. |
| .1% Barium Sulfate | VOLUMEN. Neutral enteral contrast. Low density. |
| Biphasic Injection Technique | A higher rate is injected initially, followed by a lower rate. Helps widen the period of optimum peripheral arterial enhancement. |
| Saline Flush | Helps broaden peak enhancement, allows less contrast to be used, & may lessen adverse affects of CM. |
| Corticomedullary (late arterial) Phase | 30-40 sec after injection. Optimal enhancement of the renal cortex /veins. Shows max differentiation b/w renal cortex & renal medulla. Also pancreatic phase. |
| Nephrographic (parenchymal) Phase | 70-90 sec after injection. Visualizes renal parenchyma. Renal cortex & medulla are same = good for parenchymal lesions. Portal opticacification & optimal liver enhancement = assessment of disease spread. |
| Excretory (delayed) Phase | After 3-15 min. CM is excreted into renal calyces, opacifying renal pelvis, ureters, & bladder. Demonstrates filling defects & lesions involving the urothelium. |
| Arterial Phase | 20-30 sec. Maximum opacification of the arterial enhancement. |
| Portal Venous phase | 60-70 sec (45-50 sec) after injection. Optimal gastric/intestinal wall enhancement. & liver parenchymal enhancement. |
| Retrospective Gating | Only data acquired during diastole are used for image reconstruction |
| Prospective Gating | Data acquired in an axial "step and shoot" mode & only during the diastolic portion of the R-R interval |
| Shaded Surface Display (SSD)/Surface Rendering | 3D model of a specific tissue type by limiting the displayed volumetric data, on the basis of an attenuation threshold. Adds color, lighting, & textures. |
| Volume Rendering | 3D tech that utilizes the entire required data set but adjusts the opacity of voxels in the 3D image, according to the tissue characteristics |
| Iopromide | ULTRAVIST. Low-osmolar (LOCM). NON-IONIC. Non-salts that DO NOT dissociate. Less adverse reactions |
Created by:
Crimsondrop7
Popular Radiology sets